Back to mobile site

Nomura/Instinet Reiterates Buy Rating on Dr. Reddy\'s Laboratories (DRRD:IN) (RDY)

June 28, 2026 8:24 AM EDT Send to a Friend
Nomura/Instinet analyst Saion Mukherjee reiterated a Buy rating and INR1,740.00 price target on Dr. Reddy\'s Laboratories (DRRD:IN) (NYSE: RDY).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login